Biohaven Pharma (BHVN) Withdraws Application For Troriluzole In EU

April 25, 2025 10:08 AM UTC Send to a Friend
Biohaven Pharma (NYSE: BHVN) Withdraws Application For Troriluzole In ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login